This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: William Andrew Comrie: Innovator in Orphan Disease Treatment
Introduction
William Andrew Comrie is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medicine, particularly in the diagnosis and treatment of rare diseases. His work focuses on addressing the challenges associated with CD55 deficiency and related conditions.
Latest Patents
William Andrew Comrie holds a patent for "Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE)." This patent outlines innovative methods for diagnosing and treating CHAPLE, a newly identified orphan disease. The diagnostic method involves analyzing patient samples to detect mutations in the CD55 gene and related sequences. The treatment method includes administering a composition containing complement inhibitors to alleviate symptoms of CHAPLE.
Career Highlights
Comrie's career is marked by his dedication to advancing medical science. He works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His research has the potential to significantly impact the lives of patients suffering from CHAPLE and similar conditions.
Collaborations
William Andrew Comrie collaborates with esteemed colleagues, including Ahmet Oguzhan Ozen and Helen Su. Their combined expertise enhances the research and development of effective treatments for orphan diseases.
Conclusion
William Andrew Comrie's innovative work in diagnosing and treating CHAPLE exemplifies the vital role of inventors in advancing healthcare. His contributions are paving the way for improved patient outcomes in the realm of rare diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
